Mike Marber is a physician scientist with basic research interests in the processes causing heart cell death and clinical interests in patient care during and after acute myocardial infarction. Mike Marber graduated from the Middlesex Hospital Medical School, London in 1984 having intercalated a BSc in Biophysics. After clinical training at the Brompton, St Peter’s and St George’s Hospitals he completed a PhD in physiology at University College London and postdoctoral training at University of California, San Diego. In 1996 he was appointed as a Senior Lecturer at King's College London & Consultant Cardiologist as Guy’s and St Thomas’ NHS Trust he was subsequently promoted to Professor of Cardiology in 1999. Mike Marber leads an interdisciplinary research group with interests in biomarkers of myocardial injury and drug discovery focusing on myocardial infarction and heart failure. Translational efforts are on using cardiac myosin-binding protein C (cMyC) to triage patients with chest pain and finding small molecules to disrupt the interaction between p38α mitogen-activated protein kinase (p38α) and TGF-beta activated kinase 1 binding protein 1 (TAB1).